论文部分内容阅读
泰特（TAD）的主要成份是还原型谷脱甘肽（GSH）。为探讨其对急性肾衰（ARF）的治疗价值，我院1995年1月～1998年12月共应用TAD治疗了25例药物性ARF，并设同期对照组比较。现将应用的观察情况报告如下。临床资料一、病例选择没TAD治疗组25例、对照组22例。所有病例均因原发病需
The main ingredient of TAD is reduced glutathione (GSH). To investigate its therapeutic value of acute renal failure (ARF), our hospital from January 1995 to December 1998 TAD were treated with 25 cases of drug-ARF, and set the same period the control group. The application of the observation is reported as follows. Clinical data A case selection did not TAD treatment group 25 cases, control group 22 cases. All cases were due to primary disease